...
首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >VESICLES – MECHANISM OF TRANSDERMAL PERMEATION: A REVIEW
【24h】

VESICLES – MECHANISM OF TRANSDERMAL PERMEATION: A REVIEW

机译:囊泡–透皮机制的综述

获取原文

摘要

Transdermal drug delivery is an attractive alternative to conventional techniques for administration of systemic therapeutics. The major challenge in designing transdermal drug delivery systems is to overcome the natural transport barrier of the skin. One approach is the use of vesicle formulations. Liposomes were first shown to be of potential value for topical therapy by Mezei and Gulasekharam in 1980, since then investigation continued towards development of lipid vesicles as carriers for skin delivery of drugs. But still vesicles are considered as a controversial class of dermal and transdermal carriers. This review provides an overview of the effectiveness of conventional, deformable and ethosomal vesicles as drug delivery systems as well as their possible mode of action as permeation enhancers or transdermal drug carriers. Deformable liposomes and ethosomes penetrate stratum corneum, thus releasing their drugs or proteins into systemic circulation. Vesicles as carrier systems can give rise to development of novel transdermal drug delivery systems.
机译:透皮药物递送是用于全身治疗的常规技术的有吸引力的替代方案。设计透皮给药系统的主要挑战是克服皮肤的天然运输障碍。一种方法是使用囊泡制剂。 Mezei和Gulasekharam于1980年首次证明脂质体对于局部治疗具有潜在价值,此后,研究继续朝着脂质囊泡发展为皮肤药物输送载体的方向发展。但囊泡仍被认为是有争议的一类皮肤和透皮载体。这篇综述概述了常规的,可变形的和呈核糖体的囊泡作为药物递送系统的有效性,以及它们作为渗透促进剂或透皮药物载体的可能作用方式。可变形的脂质体和脂质体穿透角质层,从而将其药物或蛋白质释放到全身循环中。囊泡作为载体系统可以引起新型透皮药物递送系统的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号